{"id":17387,"date":"2021-10-11T00:00:00","date_gmt":"2021-10-11T00:00:00","guid":{"rendered":"https:\/\/medicine.uodiyala.edu.iq\/lec-dr-qutuba-karwi\/"},"modified":"2024-04-12T16:12:45","modified_gmt":"2024-04-12T16:12:45","slug":"lec-dr-qutuba-karwi","status":"publish","type":"page","link":"https:\/\/medicine.uodiyala.edu.iq\/home\/en\/lec-dr-qutuba-karwi\/","title":{"rendered":"Ass.Prof.Dr.Qutaiba Ghanim Hussein|"},"content":{"rendered":"\n

Ass.Prof.Dr.Qutaiba Ghanim Hussein|<\/strong><\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Qutaiba Ghanim Hussein<\/strong><\/p>\n\n\n\n

Department of Pharmacology<\/p>\n\n\n\n

College of Medicine<\/p>\n\n\n\n

University of Diyala<\/p>\n\n\n\n

Diyala<\/p>\n\n\n\n

Iraq<\/p>\n\n\n\n

Higher Education and Qualifications<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Oct 2013<\/strong> \u2013 Jan 2017:         School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences, Cardiff University, United Kingdom<\/a><\/strong><\/p>\n\n\n\n

Feb 2008 \u2013 Feb 2010:        College of Pharmacy and Medical Technology, University of Petra, Amman, Jordan<\/a><\/strong><\/p>\n\n\n\n

Sep 2001 \u2013 July 2006:<\/strong>       College of Pharmacy, University of Baghdad, Baghdad, Iraq<\/strong><\/p>\n\n\n\n

Employment and Training History<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

June 2022 \u2013 present<\/strong>          <\/strong>Assistant Professor, College of Medicine, University of Diyala, Diyala, Iraq<\/p>\n\n\n\n

Feb 2017 \u2013 May 2022         <\/strong>Lecturer,College of Medicine, University of Diyala, Diyala, Iraq.<\/p>\n\n\n\n

July 2013 \u2013 Jan 2017:<\/strong>       PhD candidate, School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences, Cardiff University, United Kingdom.<\/p>\n\n\n\n

July 2010 \u2013 June 2013:<\/strong>     Assistant Lecturer and Coordinator of Department of Pharmacology, College of Medicine, University of Diyala, Diyala, Iraq.<\/p>\n\n\n\n

Jan 2009 \u2013 June 2010:<\/strong>      Research Assistant, Central Research Lab (CRL), Jordanian Pharmaceutical Manufacturing Company Plc (JPM), Amman, Jordon.<\/p>\n\n\n\n

Feb 2008 \u2013 Feb 2010<\/strong>         MSc candidate, College of Pharmacy and Medical Technology, University of Petra, Amman, Jordan<\/p>\n\n\n\n

July 2006 \u2013 Jan 2008<\/strong>         Director, Al-yosor Pharmacy (Full-time), Diyala, Iraq.<\/p>\n\n\n\n

Conference Presentations<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
    \n
  1. Qutuba G Karwi<\/strong>, Cory S Wagg, Tariq Altamimi, Gary D Lopschuk (2019). Mitochondrial protein kinase B (Akt) translocation mediates insulin-stimulated cardiac glucose oxidation. 23rd<\/sup> Annual Mazankowiski Cardiac Sciences Research Day, Edmonton, Canada. Poster.<\/strong><\/li>\n\n\n\n
  2. Qutuba G Karwi<\/strong>, Cory S Wagg, Tariq Altamimi, Gary D Lopschuk (2019). Mitochondrial protein kinase B (Akt) translocation mediates insulin-stimulated cardiac glucose oxidation. 6th<\/sup> Paediatrics Research Day, University of Alberta. Edmonton, Canada. Poster<\/strong><\/li>\n\n\n\n
  3. Qutuba G Karwi<\/strong> (2019). Targeting insulin resistance in heart failure. 4th<\/sup> EU-CARDIOPROTECTION COST Meeting, Kragujevac, Serbia. Invited Speaker<\/strong><\/li>\n\n\n\n
  4. Qutuba G. Karwi<\/strong>, Liyan Zhang, Cory S. Wagg, Wang Wang, Manoj Ghandi, Dung Thai, Hai Yan, John R. Ussher, Gavin Y. Oudit, Gary D. Lopaschuk (2018). Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction<\/strong>. American Heart Association Scientific Sessions 2018, Chicago, Illinois, USA. Poster<\/strong><\/li>\n\n\n\n
  5. Qutuba G. Karwi<\/strong>, Liyan Zhang, Abhishek Gupta, Arata Fukushima, Vaibhav Patel, Osama Abo Alrob, Tariq Altamimi, Cory S. Wagg, Raj S. Padwal, David E. Johnstone, Arya M. Sharma, Gavin Y. Oudit, Gary D. Lopaschuk (2018). Caloric restriction limits fatty acid oxidation and improves cardiac function in heart failure associated with obesity<\/strong>. 22nd<\/sup> Annual Mazankowiski Cardiac Sciences Research Day, Edmonton, Canada. Oral presentation<\/strong><\/li>\n\n\n\n
  6. Qutuba G. Karwi<\/strong>, Liyan Zhang, Abhishek Gupta, Arata Fukushima, Vaibhav Patel, Osama Abo Alrob, Tariq Altamimi, Cory S. Wagg, Raj S. Padwal, David E. Johnstone, Arya M. Sharma, Gavin Y. Oudit, Gary D. Lopaschuk (2018). Caloric restriction limits fatty acid oxidation and improves cardiac function in heart failure associated with obesity<\/strong>. 5th<\/sup> Paediatrics Research Day, University of Alberta. Edmonton, Canada. Poster<\/strong><\/li>\n\n\n\n
  7. Qutuba G. Karwi<\/strong>, Liyan Zhang, Abhishek Gupta, Arata Fukushima, Vaibhav Patel, Osama Abo Alrob, Tariq Altamimi, Cory S. Wagg, Raj S. Padwal, David E. Johnstone, Arya M. Sharma, Gavin Y. Oudit, Gary D. Lopaschuk (2018). Caloric restriction limits fatty acid oxidation and improves cardiac function in heart failure associated with obesity<\/strong>. 37th<\/sup> annual conference of the north American Section of the international Society for Heart Research. Halifax, Canada. Oral presentation<\/strong>.<\/li>\n\n\n\n
  8. Qutuba Karwi,<\/strong> Matt Whiteman, Mark Wood, Gary Baxter (2017). The effect of hydrogen sulfide (H2<\/sub>S) on reperfusion-inducedventricular arrhythmias<\/strong>. 34th<\/sup> meeting of the ISHR-ES, Hamburg, Germany, Poster<\/strong>.<\/li>\n\n\n\n
  9. Qutuba G. Karwi<\/strong>, J.S. Bice, G.F. Baxter (2017). Pre- and post-conditioning with hydrogen sulfide in vivo<\/em>: a systematic review and meta-analysis<\/strong>. 34th<\/sup> meeting of the ISHR-ES, Hamburg, Germany, Poster<\/strong>.<\/li>\n\n\n\n
  10. Qutuba Karwi,<\/strong> Matt Whiteman, Mark Wood, Gary Baxter (2017). Postconditioning with H2<\/sub>S donors: effect on reperfusion-induced ventricular arrhythmias<\/strong>. 36th<\/sup> meeting of the ISHR-NAS New Orleans, USA. Poster<\/strong><\/li>\n\n\n\n
  11. Qutuba Karwi,<\/strong> Matt Whiteman, Mark Wood, Gary Baxter (2016). Molecular mechanism of H2<\/sub>S induced cardioprotection<\/strong>. 4th International Conference on the Biology of Hydrogen Sulfide. Naples, Italy, Oral presentation<\/strong><\/li>\n\n\n\n
  12. Qutuba Karwi,<\/strong> Matt Whiteman, Mark Wood, Gary Baxter (2016). Postconditioning with H2<\/sub>S: Molecular Pharmacology. <\/strong>Ischemic Conditioning And Targeting Reperfusion Injury: A 30 Year Voyage Of Discovery. Barcelona, Spain, Poster<\/strong><\/li>\n\n\n\n
  13. Qutuba Karwi,<\/strong> Matt Whiteman, Mark Wood, Gary Baxter (2016). Postconditioning with <\/strong>mitochondrial-targeting hydrogen sulfide donor (AP39). <\/strong>XXII ISHR World Congress, Buenos Aires, Argentina. Oral presentation<\/strong><\/li>\n\n\n\n
  14. Qutuba Karwi,<\/strong> Matt Whiteman, Mark Wood, Gary Baxter (2015). Infarct limitation by GYY4137 at reperfusion, a slow-releasing hydrogen sulfide donor, in the rat in vivo. <\/strong>Pharmacology 2015, London, United Kingdom. Oral presentation<\/strong><\/li>\n\n\n\n
  15. Qutuba Karwi,<\/strong> Matt Whiteman, Mark Wood, Gary Baxter (2015). Infarct Limitation by GYY4137 at reperfusion, a slow-releasing hydrogen sulfide donor, is PI3K\/Akt-dependant with partial dependency on endothelial NO in the rat in vivo<\/em><\/strong>. 33rd<\/sup> Annual Meeting of the European Section of the ISHR, Bordeaux, France. Oral presentation and poster.<\/strong><\/li>\n<\/ol>\n\n\n\n
    Book chapters<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
      \n
    1.  Nidal A Qinna, Qutuba G Karwi<\/strong>, Nawzat Al-Jbour, Mayyas A Al-Remawi, Tawfiq M Alhussainy, Khaldoun A Al-So\u2019ud, Mahmoud M H Al Omari, Adnan A Badwan (2018). Insulin Preparations. Advances in Marine Chitin and Chitosan<\/em>, 340.<\/li>\n<\/ol>\n\n\n\n
      Peer-reviewed published papers<\/strong><\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
        \n
      1. , Liyan Zhang, Tariq R. Altamimi, Cory S. Wagg, Vaibhav Patel, Golam M. Uddin, Alice R. Joerg, Raj S. Padwal, David E. Johnstone, Arya Sharma, Gavin Y. Oudit, Gary D. Lopaschuk (2019). Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity. Diabetes Obesity and Metabolism<\/em>, 21(8):1944-1955. doi: 10.1111\/dom.13762.<\/li>\n\n\n\n
      2. Alice R Joerg, Gary D Lopaschuk (2019). Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism. Biochemcial Journal,<\/em> 476(12):1695-1712. doi: 10.1042\/BCJ20180617.<\/li>\n\n\n\n
      3. , Zhang L, Wagg CS, Wang W, Ghandi M, Thai D, Yan H, Ussher JR, Oudit GY, Lopaschuk GD (2019). Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction. Cardiovascular Diabetology<\/em>, 9;18(1):1.<\/li>\n\n\n\n
      4. , GM Uddin, KL Ho, GD Lopaschuk (2018). Energy metabolic flexibility in the failing heart. Frontiers in Cardiovascular Medicine<\/em>, 5:68.<\/li>\n\n\n\n
      5. , J.S. Bice, G.F. Baxter (2018). Pre- and post-conditioning the heart with hydrogen sulfide (H2<\/sub>S) against ischemia\/reperfusion injury in vivo<\/em>: a systematic review and meta-analysis. <\/strong>Basic research in Cardiology<\/em>, 113:6.<\/li>\n<\/ol>\n\n\n\n